Edwards Lifesciences Corp (EW) Peer Comparison

$90.74

$-0.01 (-0.01%)

As on 01-Sep-2026 16:00EDT

Market cap

$51,701 Mln

Revenue (TTM)

$6,512 Mln

P/E Ratio

53.4

P/B Ratio

4.9

Div. Yield

0 %

Edit

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Market cap ($ Mln)	51,701	232,035	201,832	151,782	133,494
Revenue ($ Mln)	6,512	46,336	46,585	25,107	11,034
Net Profit ($ Mln)	1,004.90	6,978.00	5,425.00	4,004.00	3,138.80
Net Margin (%)	15.43	15.06	11.65	15.95	28.45
RoE (%)	9.60	13.12	10.51	7.62	17.34
Price to Earnings	53.45	33.01	36.91	37.75	42.63
Price-To-Book	4.88	4.31	3.86	2.83	7.14

Income Statement ($ Mln)

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Operating Revenue	6,512.30	46,336.00	46,585.00	25,107.00	11,034.40
Cost of Revenue	1,435.70	27,629.00	20,123.00	10,416.00	3,676.80
Gross Profit	4,740.70	16,778.00	24,607.00	14,970.00	6,642.30
Operating Expenses	3,248.70	10,515.00	18,557.00	9,564.00	3,906.40
Operating Profit (EBIT)	1,829.60	8,195.00	7,932.00	5,127.00	3,451.20
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	1,417.60	7,609.00	7,511.00	4,762.00	3,805.80
Provision for Tax	439.00	597.00	2,086.00	758.00	647.90
Profit after Tax (Net Income)	1,004.90	6,978.00	5,425.00	4,004.00	3,138.80
Minority Interest	1.30	-21.00	0.00	0.00	-19.10
Consolidated Profit	382.30	3,580.00	3,420.00	2,105.00	0.00

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Shareholder's Funds	10,618.00	52,679.00	51,110.00	52,581.00	18,168.40
Minority Interest	1.30	-21.00	0.00	0.00	-19.10
Non-Current Liabilities	1,634.30	45,298.00	39,639.00	31,681.00	656.00
Current Liabilities	1,507.90	15,069.00	17,814.00	8,105.00	1,922.90
Total Liabilities	13,697.20	110,343.00	86,713.00	83,464.00	20,631.20

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Non-Current Assets	7,048.20	89,809.00	84,698.00	78,986.00	11,333.90
Current Assets	6,818.90	23,365.00	24,517.00	13,381.00	9,542.70
Total Assets	13,697.20	110,343.00	86,713.00	83,464.00	20,631.20
Total Debt*	704.40	42,549.00	32,608.00	26,558.00	0.00
Net Current Assets	5,311.00	8,296.00	0.00	5,276.00	7,619.80

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Cash From Operating Activities	1,595.20	7,818.00	9,566.00	6,416.00	3,030.50
Cash Flow from Investing Activities	-712.90	-4,047.00	-2,422.00	-1,196.00	665.80
Cash from Financing Activities	-956.80	1,801.00	-6,309.00	-2,961.00	-2,364.10
Net Cash Inflow / Outflow	--	--	--	--	--

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
ROCE (%)	9.88	7.69	10.03	5.25	16.46
ROE (%)	9.60	13.12	10.51	7.62	17.34
ROA (%)	6.64	5.76	4.69	4.24	14.06
EBIT Margin (%)	13.79	18.62	13.35	20.13	33.76
Net Margin (%)	15.43	15.06	11.65	15.95	28.45
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Revenue Growth (%)	14.55	7.23	8.06	4.56	20.66
EBIT Growth (%)	-44.97	1.20	-26.60	15.73	24.96
Net Profit Growth (%)	-75.75	5.98	-61.19	17.32	20.37
EPS Growth (%)	-75.16	7.77	-61.19	20.09	21.65
Book Value Growth (%)	2.48	6.26	1.54	2.10	3.40

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Price / Earnings	46.20	32.43	33.55	45.04	71.47
Price / Book Value	4.80	4.09	4.20	3.10	11.45
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	32.23	21.61	19.48	25.42	49.76
Market Cap ($ Cr)	--	--	--	--	--

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Debt to Equity	0.06	0.74	0.00	0.48	0.00
Short term debt to equity ratio	0.00	0.06	0.06	0.03	0.00
Current Ratio	4.52	1.55	1.38	1.65	4.96
Quick Ratio	3.77	1.18	0.97	1.25	3.91
Interest Coverage	62.40	6.19	12.79	62.05	--

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Debtors to sales (%)	14.68	20.40	18.46	15.79	16.08
Asset Turnover	0.43	0.38	0.40	0.27	0.49
Receivable days	49.35	82.76	61.20	61.72	54.16
Inventory Days	304.57	68.39	117.44	91.69	177.54
Payable days	58.48	44.06	78.11	68.44	23.93
Cash Conversion Cycle	295.43	107.10	100.53	84.97	207.78

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.